Edouard Tuaillon1,2, Johanes Viljoen1,3,4, Pierre Dujols1,5, Gilles Cambonie6, Pierre-Alain Rubbo1, Nicolas Nagot1,5, Ruth M Bland3,7, Stéphanie Badiou8, Marie-Louise Newell9, Philippe Van de Perre1,2. 1. UMR Inserm U1058, EFS, Université Montpellier 1, Montpellier, France. 2. CHRU de Montpellier, Département de Bactériologie-Virologie, Montpellier, France. 3. Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Durban, South Africa. 4. Department Virology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, South Africa. 5. CHRU de Montpellier, Département d'Information Médicale, Montpellier, France. 6. CHRU de Montpellier, Département de Néonatologie, Montpellier, France. 7. Royal Hospital for Sick Children, Glasgow, UK. 8. Département de Biochimie, CHRU Montpellier, Université de Montpellier, Montpellier, France. 9. Faculty of Medicine, University of Southampton, Southampton, UK.
Abstract
BACKGROUND: Subclinical mastitis (SCM) is a frequent, but poorly characterized entity that may influence immune development of breastfed infants. Mechanisms driving the emergence of SCM and changes in immunological content of human milk during SCM remain to be explored. In this study, the breast milk environment was to describe during SCM. METHODS: One hundred and ten samples of mature breast milk were collected from 44 healthy, HIV-negative mothers, included in a large infant feeding intervention cohort (ANRS 1271/Vertical Transmission Study). Immune markers related to inflammatory/anti-inflammatory balances and secreted in response to bacterial exposure were explored in SCM breast milk samples (Na/K ratio > 1) and compared to non-SCM controls. RESULTS: SCM was observed in 23% of women (95% confidence interval (CI): 21-24) and associated with higher levels of inflammatory markers (β2 microgobulin, PS100A9, TNF-α, IL-6, IL-8, IL-17, and RANTES) and Th1-related cytokines (IL-2R, IL-12p40/70, IFN-α, IFN-γ, CXCL-9, andIP-10). High levels of factors secreted in response to bacteria and lipopolysaccharide (LPS) exposure were observed in SCM breast milk samples (MIP-1α, MIP-1β, LPS binding protein, α-defensins, and antileukoproteinase 1). CONCLUSION: SCM is associated with important changes in breast milk microenvironment, with a proinflammatory/Th1-cytokine predominant profile. During SCM, cytokine imbalances in breast milk may have a notable influence on mucosal immune system of the infant early in life.
BACKGROUND: Subclinical mastitis (SCM) is a frequent, but poorly characterized entity that may influence immune development of breastfed infants. Mechanisms driving the emergence of SCM and changes in immunological content of human milk during SCM remain to be explored. In this study, the breast milk environment was to describe during SCM. METHODS: One hundred and ten samples of mature breast milk were collected from 44 healthy, HIV-negative mothers, included in a large infant feeding intervention cohort (ANRS 1271/Vertical Transmission Study). Immune markers related to inflammatory/anti-inflammatory balances and secreted in response to bacterial exposure were explored in SCM breast milk samples (Na/K ratio > 1) and compared to non-SCM controls. RESULTS: SCM was observed in 23% of women (95% confidence interval (CI): 21-24) and associated with higher levels of inflammatory markers (β2 microgobulin, PS100A9, TNF-α, IL-6, IL-8, IL-17, and RANTES) and Th1-related cytokines (IL-2R, IL-12p40/70, IFN-α, IFN-γ, CXCL-9, andIP-10). High levels of factors secreted in response to bacteria and lipopolysaccharide (LPS) exposure were observed in SCM breast milk samples (MIP-1α, MIP-1β, LPS binding protein, α-defensins, and antileukoproteinase 1). CONCLUSION: SCM is associated with important changes in breast milk microenvironment, with a proinflammatory/Th1-cytokine predominant profile. During SCM, cytokine imbalances in breast milk may have a notable influence on mucosal immune system of the infant early in life.
Authors: M C Neville; J C Allen; P C Archer; C E Casey; J Seacat; R P Keller; V Lutes; J Rasbach; M Neifert Journal: Am J Clin Nutr Date: 1991-07 Impact factor: 7.045
Authors: R Garofalo; S Chheda; F Mei; K H Palkowetz; H E Rudloff; F C Schmalstieg; D K Rassin; A S Goldman Journal: Pediatr Res Date: 1995-04 Impact factor: 3.756
Authors: Hoosen M Coovadia; Nigel C Rollins; Ruth M Bland; Kirsty Little; Anna Coutsoudis; Michael L Bennish; Marie-Louise Newell Journal: Lancet Date: 2007-03-31 Impact factor: 79.321
Authors: E Hailman; H S Lichenstein; M M Wurfel; D S Miller; D A Johnson; M Kelley; L A Busse; M M Zukowski; S D Wright Journal: J Exp Med Date: 1994-01-01 Impact factor: 14.307
Authors: Lorena Ruiz; Irene Espinosa-Martos; Cristina García-Carral; Susana Manzano; Michelle K McGuire; Courtney L Meehan; Mark A McGuire; Janet E Williams; James Foster; Daniel W Sellen; Elizabeth W Kamau-Mbuthia; Egidioh W Kamundia; Samwel Mbugua; Sophie E Moore; Linda J Kvist; Gloria E Otoo; Kimberly A Lackey; Katherine Flores; Rossina G Pareja; Lars Bode; Juan M Rodríguez Journal: Front Immunol Date: 2017-06-30 Impact factor: 7.561
Authors: Roxane Schaub; Stéphanie Badiou; Johannes Viljoen; Pierre Dujols; Karine Bolloré; Philippe Van de Perre; Marie-Louise Newell; Ruth Bland; Nicolas Nagot; Edouard Tuaillon Journal: J Transl Med Date: 2018-10-25 Impact factor: 5.531
Authors: Martyna Pajewska-Szmyt; Elena Sinkiewicz-Darol; Renata Gadzała-Kopciuch Journal: Environ Sci Pollut Res Int Date: 2019-01-28 Impact factor: 4.223
Authors: Jacqueline María Valverde-Villegas; Mar Naranjo-Gomez; Mélusine Durand; David Rutagwera; Anne-Sophie Bedin; Chipepo Kankasa; Ségolène Debiesse; Nicolas Nagot; Edouard Tuaillon; Philippe Van de Perre; Jean-Pierre Molès Journal: Front Cell Infect Microbiol Date: 2020-09-24 Impact factor: 5.293